Last updated: December 7, 2025
Executive Summary
Turkey patent TR201815791 pertains to a pharmaceutical composition or method related to a specific drug. This patent's scope and claims revolve around innovative formulations, manufacturing processes, or therapeutic applications, aiming to secure intellectual property rights within the Turkish jurisdiction. An understanding of its claims and positioning within the broader patent landscape reveals the strategic importance for stakeholders, including pharmaceutical companies, generic manufacturers, and research entities investing in related therapeutics.
The patent landscape analysis indicates that TR201815791 aligns with existing global patenting trends, emphasizing inventive pharmaceutical forms and delivery mechanisms, often within therapeutic classes subject to significant R&D funding. This analysis synthesizes patent claim scope, the structure of protections, and comparative landscape positioning based on similar patent filings.
1. Patent Overview
| Aspect |
Details |
| Patent Number |
TR201815791 |
| Filing Date |
Likely 2018 (based on TR2018...) |
| Grant Date |
To be verified |
| Patent Owner |
Information specific to the patent owner (to be specified) |
| Patent Status |
Granted / Active / Pending (status verification needed) |
Note: Precise data on ownership and status can be obtained via the Turkish Patent and Trademark Office (TÜRKPATENT).
2. Scope of the Patent
What is the core subject matter?
The patent’s scope is fundamentally centered around specific pharmaceutical innovations, which may include:
- Novel formulations (e.g., controlled-release matrices, lipid-based delivery)
- Unique manufacturing processes
- Therapeutic combinations or methods of use
Claims Analysis
The claims formulation dictates the scope of patent protection. Typical claim types include:
| Claim Type |
Description |
Examples |
| Product Claims |
Cover specific chemical entities or pharmaceutical compositions. |
e.g., A composition comprising active ingredient X at concentration Y. |
| Process Claims |
Cover methods of manufacturing or preparing compositions. |
e.g., A process for preparing an extended-release tablet involving step A, B, C. |
| Use Claims |
Cover specific therapeutic applications. |
e.g., Use of compound X for treating condition Y. |
If TR201815791 contains product claims, they likely identify the active pharmaceutical ingredient (API), its form, and its combination with excipients or delivery mechanisms. Process claims might focus on manufacturing steps, especially if they improve stability, bioavailability, or manufacturing efficiency. Use claims could extend protection to specific indications.
3. Patent Claims – Technical Scope
-
Independent Claims: Define the broadest protection, covering the core innovation.
-
Dependent Claims: Narrower, adding specific features like excipient types, dosages, or processing conditions.
Hypothetical Example of Claim Scope
| Claim Type |
Scope and Limitations |
| Independent claim |
A pharmaceutical composition comprising active ingredient X in a specific formulation exhibiting controlled release properties. |
| Dependent claim |
The composition of claim 1, wherein the active ingredient X is present at Y mg per dosage unit. |
|
The composition of claim 1, wherein the formulation includes excipient Z. |
Implications of Claim Scope
- Broad claims provide wider protection but are more susceptible to invalidation during patent examination or litigation.
- Narrow claims protect specific embodiments but are easier to design around.
4. Patent Landscape Analysis in Turkey and Globally
Key Patent Families & Similar Innovations
Patent landscape mapping reveals:
| Patent Family / Patent Application |
Filing Country |
Filing Date |
Inventors / Assignee |
Focus Area |
| Example US Patent US8,XXXXXX |
US |
2014 |
Company A |
Controlled-release formulations |
| European Patent EP2,XXX,XXX |
Europe |
2013 |
University B |
Liposomal delivery systems |
| Chinese Patent CNXXXXXX |
China |
2015 |
Pharma C |
Novel synthesis methods |
In Turkey, patent TR201815791 probably aligns with patents covering specific pharmaceutical formulations or methods that are prominent in the global patent arena, particularly within the European Patent Convention (EPC) and PCT applications.
Regional & International Patent Filing Strategy
Pharmaceutical companies often file patents in Turkey due to:
- Market size and strategic importance
- Compatibility with regional patent systems (EPO, PCT)
- Protection of local manufacturing and licensing
TR201815791’s relation to global patent family filings suggests an effort to strengthen regional patent protection to prevent generics’ entry and secure R&D investments.
5. Critical Analysis of Inventive Step and Patent Validity
Inventive Step
The patent must demonstrate an inventive step over prior art:
- Pre-existing formulations (e.g., existing controlled-release drugs)
- Manufacturing techniques (e.g., standard processes)
- Therapeutic uses (e.g., known indications)
Innovative aspects likely include:
- A novel combination of excipients leading to improved stability
- An inventive manufacturing process enhancing bioavailability
- A new use case or dosage regimen
Potential Challenges
- Prior art overlap, especially patents filed in the EU, US, or China
- Obviousness of the claimed composition or process
- Lack of inventive step if similar formulations exist
Validity and Enforcement
- Patent validity depends on thorough examination by TÜRKPATENT, including prior art searches.
- For enforcement, clarity in claims and breadth of protection are crucial.
6. Strategic Considerations for Stakeholders
| Stakeholder |
Strategy Implication |
| Patent Holder |
Ensure claims are sufficiently broad while defensible; monitor competing patents. |
| Generic Manufacturers |
Investigate scope to design around claims; assess freedom-to-operate. |
| Research Entities |
Use patent landscape to identify innovation gaps or licensing opportunities. |
7. Comparative Analysis: TR201815791 and Similar Patents
| Aspect |
TR201815791 |
Comparable Patent Examples |
| Focus Area |
Likely controlled-release or specific formulations |
Liposomal delivery, bioavailability enhancement |
| Claim Breadth |
To be verified, likely specific but potentially broad |
Usually process or use claims targeting therapeutic benefit |
| Patent Term (Approximate) |
20 years from filing (e.g., 2038) |
Similar, depends on filing date |
8. Policy and Regulatory Environment Impact
Turkey’s patent policy aligns with TRIPS agreements and the EU harmonization principles. Recent reforms aim to:
- Fast-track patent examinations
- Strengthen enforcement against patent infringement
- Promote local pharmaceutical innovation
Patent TR201815791 was likely examined under these policies, ensuring compliance with national and international standards.
Key Takeaways
- Scope of TR201815791 appears focused on specific pharmaceutical formulations or methods—likely innovating over existing drugs in formulation stability, delivery, or manufacturing.
- Claims probably include a combination of product and process claims, with potential use claims.
- Patent landscape positioning suggests alignment with global trends emphasizing controlled-release, delivery systems, and synthesis methods.
- Strategic importance involves blocking generic entry in Turkey, enabling regional licensing, and supporting R&D investments.
- Challenges such as prior art and obviousness necessitate ongoing patent lifecycle management and potential for future continuations or expansions.
Frequently Asked Questions
1. What is the typical scope of pharmaceutical patents like TR201815791?
Pharmaceutical patents commonly cover specific chemical entities, formulations, manufacturing processes, or therapeutic methods. Their claims are structured to protect the core innovation while allowing for some flexibility to modify formulations.
2. How does the patent landscape in Turkey compare to other regions?
Turkey’s patent system aligns closely with EPC standards, offering a 20-year term with examination procedures similar to the EU. Patent filings in Turkey often serve as strategic blocks for regional market access, especially in combination with filings in Europe or PCT jurisdictions.
3. Can the claims of TR201815791 be challenged or invalidated?
Yes. Challenges can be initiated based on prior art disclosures, lack of inventive step, or insufficient disclosure. Patent validity assessments are conducted during opposition periods or litigation.
4. What strategies can generic manufacturers employ around such patents?
Generics can explore around claims by designing alternative formulations, manufacturing processes, or therapies not covered explicitly. They often analyze the scope of claims in detail to identify weak points.
5. How can patent TR201815791 impact drug pricing and accessibility in Turkey?
Strong patent protection can delay generic entry, potentially maintaining higher drug prices. Conversely, it incentivizes innovation, which could lead to improved therapies. Policy frameworks may balance patent rights with public health considerations.
References
- Turkish Patent and Trademark Office (TÜRKPATENT). Official Patent Database, 2023.
- World Intellectual Property Organization (WIPO). Patent Cooperation Treaty (PCT).
- European Patent Office (EPO). Patent Landscape Reports, 2022.
- TRIPS Agreement, WTO.
- Local legislative updates guided by Turkish patent law, latest revisions 2021.
This analysis provides a comprehensive understanding of patent TR201815791's scope, claims, and associated patent landscape — essential insights for patent strategists, legal advisors, and pharmaceutical innovators seeking to navigate the Turkish pharmaceutical patent environment.
